|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q89908265
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235815.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q89908265
|
|
024
|
|
|
‡a
0000-0002-9058-8076
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q89908265
|
|
100
|
0 |
|
‡a
Nina Kramer
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Nina Kramer
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
|
|
670
|
|
|
‡a
Author's Companion Animals as Models for Inhibition of STAT3 and STAT5
|
|
670
|
|
|
‡a
Author's Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses
|
|
670
|
|
|
‡a
Author's DRUGPATH - a novel bioinformatic approach identifies DNA-damage pathway as a regulator of size maintenance in human ESCs and iPSCs
|
|
670
|
|
|
‡a
Author's Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells.
|
|
670
|
|
|
‡a
Author's Generation of Differentiating and Long-Living Intestinal Organoids Reflecting the Cellular Diversity of Canine Intestine
|
|
670
|
|
|
‡a
Author's High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts
|
|
670
|
|
|
‡a
Author's Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment
|
|
670
|
|
|
‡a
Author's Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation.
|
|
670
|
|
|
‡a
Author's Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development
|
|
670
|
|
|
‡a
Author's The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation
|
|
909
|
|
|
‡a
(orcid) 0000000290588076
‡9
1
|
|
919
|
|
|
‡a
cancerassociatedfibroblastderivedwnt2increasestumorangiogenesisincoloncancer
‡A
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
‡9
1
|
|
919
|
|
|
‡a
generationofdifferentiatingandlonglivingintestinalorganoidsreflectingthecellulardiversityofcanineintestine
‡A
Generation of Differentiating and Long-Living Intestinal Organoids Reflecting the Cellular Diversity of Canine Intestine
‡9
1
|
|
919
|
|
|
‡a
highemtsignaturescoreofinvasivenonsmallcelllungcancernsclccellscorrelateswithnfκbdrivencolonystimulatingfactor2csf2gmcsfsecretionbyneighboringstromalfibroblasts
‡A
High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts
‡9
1
|
|
919
|
|
|
‡a
increasedcomplexityincarcinomasanalyzingandmodelingtheinteractionofhumancancercellswiththeirmicroenvironment
‡A
Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment
‡9
1
|
|
919
|
|
|
‡a
companionanimalsasmodelsforinhibitionofstat3andstat5
‡A
Companion Animals as Models for Inhibition of STAT3 and STAT5
‡9
1
|
|
919
|
|
|
‡a
comparisonofcancercellsin2dvs3dculturerevealsdifferencesinaktmtors6ksignalinganddrugresponses
‡A
Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses
‡9
1
|
|
919
|
|
|
‡a
drugpathanovelbioinformaticapproachidentifiesdnadamagepathwayasaregulatorofsizemaintenanceinhumanescsandipscs
‡A
DRUGPATH - a novel bioinformatic approach identifies DNA-damage pathway as a regulator of size maintenance in human ESCs and iPSCs
‡9
1
|
|
919
|
|
|
‡a
exclusionfromspheroidformationidentifieslossofessentialcellcelladhesionmoleculesincoloncancercells
‡A
Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells.
‡9
1
|
|
919
|
|
|
‡a
lobatinbinhibitsnpmalkandnfκbattenuatinganaplasticlargecelllymphomagenesisandlymphendothelialtumourintravasation
‡A
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation.
‡9
1
|
|
919
|
|
|
‡a
modelinghumancarcinomasphysiologicallyrelevant3dmodelstoimproveanticancerdrugdevelopment
‡A
Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development
‡9
1
|
|
919
|
|
|
‡a
germacranolidesesquiterpenelactoneneuroleninbofthemedicinalplantneurolaenalobata50rbrexcassinhibitsnpmalkdrivencellexpansionandnfκbdriventumourintravasation
‡A
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation
‡9
1
|
|
996
|
|
|
‡2
NTA|069025045
|
|
996
|
|
|
‡2
DNB|117125332X
|
|
996
|
|
|
‡2
LC|no 95046609
|
|
996
|
|
|
‡2
LNB|LNC10-000020009
|
|
996
|
|
|
‡2
NTA|121877639
|
|
996
|
|
|
‡2
ISNI|0000000394569523
|
|
996
|
|
|
‡2
ISNI|0000000043187988
|
|
996
|
|
|
‡2
PLWABN|9810674168005606
|
|
996
|
|
|
‡2
NUKAT|n 2014145578
|
|
996
|
|
|
‡2
ISNI|0000000368231916
|
|
996
|
|
|
‡2
DNB|138832404
|
|
996
|
|
|
‡2
NTA|071027637
|
|
996
|
|
|
‡2
DNB|115508597
|
|
996
|
|
|
‡2
DNB|1061165426
|
|
996
|
|
|
‡2
SKMASNL|vtls012214542
|
|
996
|
|
|
‡2
ISNI|0000000368231924
|
|
996
|
|
|
‡2
DNB|1045066389
|
|
996
|
|
|
‡2
NTA|38952784X
|
|
996
|
|
|
‡2
NII|DA08033896
|
|
996
|
|
|
‡2
LC|n 79117360
|
|
996
|
|
|
‡2
NTA|401558754
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
